Therefore, the measurement of the concentrations of MMP8 in the GCF of patients by dentists and/or dermatologists could be a beneficial, novel, chair-side diagnostic tool for AD diagnosis since the method is non-invasive and fast (taking approximately 2 min in total for the sample collection), opening the door to future personalized treatments. The gene discussed is MMP8; the disease is Alzheimer disease.